Condition: Atrial Fibrillation · Sponsor: Institut Mutualiste Montsouris
Pulmonary vein isolation is the main treatment of paroxysmal and persistent atrial fibrillation. The aim of our study is to prospectively compare the efficacy and safety of the 3 options of radiofrequency delivery with QDOT Micro™, with systematic use of catheter stabilization tools and tighter lesions
This description comes directly from the study's public registry record.
Naly ANDRIAMBAO · +33156616439 · naly.andriambao@imm.fr
Always discuss trial participation with your own doctor first.
| Institut Mutualiste Montsouris | Paris, Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06647251